Literature DB >> 19666893

Peroxisomes, myelination, and axonal integrity in the CNS.

Myriam Baes1, Patrick Aubourg.   

Abstract

Peroxisomes are ubiquitous organelles with multiple metabolic functions, but their precise role in the maintenance of tissues is not well understood. All diseases caused by partial or complete peroxisome dysfunction are characterized by a variety of neurological abnormalities, underscoring the importance of peroxisomes in nervous tissue. The interrelationship between metabolic abnormalities, histological changes, and clinical signs in these peroxisomal diseases has not yet been clarified. During the past decade, a more systematic study of the consequences of peroxisome dysfunction was possible through the generation of knockout mice with generalized or conditional inactivation of peroxisomal proteins. It appears that peroxisomes are necessary for the preservation of axonal integrity and for the formation and maintenance of myelin.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19666893     DOI: 10.1177/1073858409336297

Source DB:  PubMed          Journal:  Neuroscientist        ISSN: 1073-8584            Impact factor:   7.519


  24 in total

Review 1.  Myelination and support of axonal integrity by glia.

Authors:  Klaus-Armin Nave
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

2.  Impaired Peroxisomal Fitness in Obese Mice, a Vicious Cycle Exacerbating Adipocyte Dysfunction via Oxidative Stress.

Authors:  Lingjuan Piao; Debra Dorotea; Songling Jiang; Eun Hee Koh; Goo Taeg Oh; Hunjoo Ha
Journal:  Antioxid Redox Signal       Date:  2019-12-20       Impact factor: 8.401

3.  Lipid homeostasis and inflammatory activation are disturbed in classically activated macrophages with peroxisomal β-oxidation deficiency.

Authors:  Ivana Geric; Yulia Y Tyurina; Olga Krysko; Dmitri V Krysko; Evelyn De Schryver; Valerian E Kagan; Paul P Van Veldhoven; Myriam Baes; Simon Verheijden
Journal:  Immunology       Date:  2017-10-26       Impact factor: 7.397

4.  Peroxisomes contribute to oxidative stress in neurons during doxorubicin-based chemotherapy.

Authors:  Jose F Moruno-Manchon; Ndidi-Ese Uzor; Shelli R Kesler; Jeffrey S Wefel; Debra M Townley; Archana Sidalaghatta Nagaraja; Sunila Pradeep; Lingegowda S Mangala; Anil K Sood; Andrey S Tsvetkov
Journal:  Mol Cell Neurosci       Date:  2017-11-24       Impact factor: 4.314

Review 5.  Peroxisome deficient invertebrate and vertebrate animal models.

Authors:  Paul P Van Veldhoven; Myriam Baes
Journal:  Front Physiol       Date:  2013-11-22       Impact factor: 4.566

Review 6.  Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models.

Authors:  Roman Chrast; Gesine Saher; Klaus-Armin Nave; Mark H G Verheijen
Journal:  J Lipid Res       Date:  2010-11-09       Impact factor: 5.922

Review 7.  Does PGC1α/FNDC5/BDNF Elicit the Beneficial Effects of Exercise on Neurodegenerative Disorders?

Authors:  Mohammad Jodeiri Farshbaf; Kamran Ghaedi; Timothy L Megraw; Jennifer Curtiss; Mahsa Shirani Faradonbeh; Pooneh Vaziri; Mohammad Hossein Nasr-Esfahani
Journal:  Neuromolecular Med       Date:  2015-11-26       Impact factor: 3.843

8.  Peripheral nervous system defects in a mouse model for peroxisomal biogenesis disorders.

Authors:  M Gartz Hanson; Veronica L Fregoso; Justin D Vrana; Chandra L Tucker; Lee A Niswander
Journal:  Dev Biol       Date:  2014-08-28       Impact factor: 3.582

9.  Aging lowers PEX5 levels in cortical neurons in male and female mouse brains.

Authors:  Ndidi-Ese Uzor; Diego Morales Scheihing; Gab Seok Kim; Jose Felix Moruno-Manchon; Liang Zhu; Caroline R Reynolds; Jessica M Stephenson; Aleah Holmes; Louise D McCullough; Andrey S Tsvetkov
Journal:  Mol Cell Neurosci       Date:  2020-08-07       Impact factor: 4.314

10.  Peroxisomal biogenesis in ischemic brain.

Authors:  Jennifer M Young; Jonathan W Nelson; Jian Cheng; Wenri Zhang; Sarah Mader; Catherine M Davis; Richard S Morrison; Nabil J Alkayed
Journal:  Antioxid Redox Signal       Date:  2015-01-10       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.